| Product Name | Colorado WAC Disclosure Form | Date Updated |
|---|---|---|
| ABSORICA LD™ (Isotretinoin) Capsules | Disclosure Form | August 2023 |
| BromSite® (bromfenac ophthalmic solution) 0.075% | Disclosure Form | August 2023 |
| CEQUA™ (cyclosporine ophthalmic solution) 0.09% | Disclosure Form | August 2023 |
| HALOG® Solution (Halcinonide Topical Solution, USP) 0.1% | Disclosure Form | August 2023 |
| ILUMYA®(tildrakizumab-asmn) | Disclosure Form | August 2023 |
| INFUGEM (gemcitabine hydrochloride in 0.9% sodium chloride injection) | Disclosure Form | August 2023 |
| LEVULAN® KERASTICK ® | Disclosure Form | August 2023 |
| ODOMZO ®(sonidegib) | Disclosure Form | August 2023 |
| ULTRAVATE® (halobetasol propionate) Lotion | Disclosure Form | August 2023 |
| WINLEVI®(clascoterone) cream 1% | Disclosure Form | August 2023 |
| XELPROS™ (latanoprosto phthalmicemulsion) | Disclosure Form | August 2023 |
| YONSA® (abiraterone acetate) tablets | Disclosure Form | August 2023 |
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.